Scientific Publications Search Search Author Impact Factor Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Akalin, Altuna Dr. (2) Beule, Dieter Dr. (1) Blüthgen, Nils (1) Chekulaeva, Marina Dr. (1) Chen, Wei Prof. Dr. (1) Daumke, Oliver Prof. Dr. (1) Franke, Vedran Dr. (2) Hergeselle, Martha (1) Hübner, Norbert Prof. Dr. (1) Kammertöns, Thomas Dr. (1) Kärgel, Eva Dr. (1) Kolesnichenko, Marina Dr. (1) Lorenz, Felix Dr. (2) Lusatis, Simone (1) Mathas, Stephan Dr. (6) Meyer, Irmtraud Margret Prof. Dr. (1) Ohler, Uwe Prof. Dr. (1) Patone, Giannino Dr. (1) Poncette, Lucia (1) Rajewsky, Nikolaus Prof. Dr. (1) Scheidereit, Claus Prof. Dr. (1) Selbach, Matthias Prof. Dr. (7) Sommer, Christian (1) Uckert, Wolfgang Prof. Dr. (2) Vieira e Vieira, Carlos Henrique (1) Woehler, Andrew Dr. (1) (-) Blankenstein, Thomas Prof. Dr. (2) (-) Daniel, Peter Prof. Dr. (1) (-) Janz, Martin Dr. (4) (-) Leisegang, Matthias Dr. (1) (-) Wollert-Wulf, Brigitte (2) 1998 (2) 2000 (2) 2003 (7) 2004 (3) 2005 (5) (-) 2006 (5) 2007 (3) 2008 (4) 2009 (3) 2010 (5) 2012 (5) 2013 (2) 2014 (4) 2015 (5) 2016 (3) 2017 (5) 2018 (1) (-) 2019 (1) 2020 (4) 2021 (4) (-) Biology of Malignant Lymphomas (4) Genetics and Genomics of Cardiovascular Diseases (1) (-) Molecular Cell Biology and Gene Therapy (3) Molecular Immunology and Gene Therapy (7) Molecular Immunotherapy (1) Translational Oncology of Solid Tumors (1) 6 Results: Active Filter: Blankenstein, Thomas Prof. Dr.Daniel, Peter Prof. Dr.Janz, Martin Dr.Leisegang, Matthias Dr.Wollert-Wulf, BrigitteBiology of Malignant LymphomasMolecular Cell Biology and Gene Therapy20062019 Sort: Result score Newest to oldest Oldest to newest January 02, 2019 in J Clin Invest Effective NY-ESO-1-specific MHC II-restricted T cell receptors from antigen-negative hosts enhance tumor regression L. Poncette X. Chen F.K.M. Lorenz T. Blankenstein November 01, 2006 in Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert May 15, 2006 in Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas April 01, 2006 in Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel March 15, 2006 in Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou February 01, 2006 in Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken
January 02, 2019 in J Clin Invest Effective NY-ESO-1-specific MHC II-restricted T cell receptors from antigen-negative hosts enhance tumor regression L. Poncette X. Chen F.K.M. Lorenz T. Blankenstein
November 01, 2006 in Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert
May 15, 2006 in Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas
April 01, 2006 in Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel
March 15, 2006 in Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou
February 01, 2006 in Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken
